Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives $94.80 Consensus Target Price from Analysts

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) have earned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $94.80.

A number of equities research analysts have recently issued reports on the company. Zacks Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Thursday, September 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research report on Saturday, September 27th. Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target on the stock in a research report on Wednesday, September 24th. Canaccord Genuity Group dropped their price target on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Friday, August 8th. Finally, Wall Street Zen lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Cerity Partners LLC raised its position in Prestige Consumer Healthcare by 3.7% during the first quarter. Cerity Partners LLC now owns 3,666 shares of the company’s stock valued at $315,000 after buying an additional 132 shares during the period. UMB Bank n.a. grew its stake in Prestige Consumer Healthcare by 81.8% in the second quarter. UMB Bank n.a. now owns 320 shares of the company’s stock valued at $26,000 after purchasing an additional 144 shares in the last quarter. KBC Group NV grew its stake in Prestige Consumer Healthcare by 7.4% in the first quarter. KBC Group NV now owns 2,199 shares of the company’s stock valued at $189,000 after purchasing an additional 151 shares in the last quarter. Bank of Montreal Can grew its stake in Prestige Consumer Healthcare by 2.0% in the second quarter. Bank of Montreal Can now owns 9,351 shares of the company’s stock valued at $747,000 after purchasing an additional 182 shares in the last quarter. Finally, Xponance Inc. grew its stake in Prestige Consumer Healthcare by 5.5% in the first quarter. Xponance Inc. now owns 3,766 shares of the company’s stock valued at $324,000 after purchasing an additional 196 shares in the last quarter. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 0.5%

Shares of Prestige Consumer Healthcare stock opened at $62.85 on Friday. The business’s fifty day moving average price is $65.99 and its two-hundred day moving average price is $76.62. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The company has a market capitalization of $3.09 billion, a P/E ratio of 14.75, a PEG ratio of 2.00 and a beta of 0.44. Prestige Consumer Healthcare has a 1-year low of $61.28 and a 1-year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). The company had revenue of $249.53 million for the quarter, compared to analyst estimates of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The firm’s revenue for the quarter was down 6.6% on a year-over-year basis. During the same period last year, the firm earned $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, research analysts forecast that Prestige Consumer Healthcare will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.